fda compounding glp-1 warning letters october 2025 Letter to FDA's Office of Prescription Drug Promotion, CDER – Partnership for Safe Medicines Trends In FDA FY 2025

The thing that protects your joints

While the manufacturer is on the list of authorized GLP-1 importers, FDA inspectors found the company relabeled APIs from another site in a potential attempt to circumvent safeguards.

Learn what clinical trials reveal about this GLP-1 medication's side effects, why bleeding may occur during treatment, and when to contact your doctor about abnormal vaginal bleeding.

Emodin used to be in our Cortisol Blocker formula (now named Calm), however, because it is such a potent compound with far more particular use cases, we felt it was warranted to separate it into its own product entirely to maximize flexibility of use, dosage titration, etc